Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Abbott’s Q1 device sales slump on Boston Scientific stent royalty losses
Health care titan Abbott Labs’ Q1 device sales slump on decreasing royalty payments from Boston Scientific’s Promus stents.
2. St. Jude slumps along with its CRM sales
St. Jude Medical beats Wall Street’s expectations for Q1, but continued sluggishness in cardiac rhythm management sales chills investor confidence.
1. DePuy ASR recall takes $271M from J&J’s Q1 bottom line
Litigation expenses and recall costs related to Johnson & Johnson’s recall of the DePuy ASR hip implant cost the health care conglomerate $271 million in profits during the 1st quarter.
